Heming Zhou

950 total citations · 1 hit paper
12 papers, 639 citations indexed

About

Heming Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Heming Zhou has authored 12 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Heming Zhou's work include Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Heming Zhou is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Heming Zhou collaborates with scholars based in China and Hong Kong. Heming Zhou's co-authors include Jigang Zhang, Xue Zhang, Li Qin, Liu Gao-lin, Pu Wang, Shoubing Huang, Dechang Sheng, Yuanyuan Wang, Chenchen Xu and Beijing Tian and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Experimental Cell Research.

In The Last Decade

Heming Zhou

11 papers receiving 637 citations

Hit Papers

Targeting cancer stem cells for reversing therapy resista... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heming Zhou China 8 358 206 176 122 71 12 639
Yue Qi China 13 219 0.6× 130 0.6× 52 0.3× 125 1.0× 16 0.2× 39 587
Magdalena Olbryt Poland 13 334 0.9× 126 0.6× 168 1.0× 725 5.9× 270 3.8× 25 1.2k
Guangbo Tang China 11 218 0.6× 79 0.4× 87 0.5× 70 0.6× 11 0.2× 22 421
Kamal Pandey India 11 191 0.5× 320 1.6× 83 0.5× 119 1.0× 9 0.1× 38 653
Yanfei Ma China 13 751 2.1× 79 0.4× 361 2.1× 366 3.0× 12 0.2× 28 985
Dan Zong China 14 453 1.3× 109 0.5× 214 1.2× 92 0.8× 17 0.2× 67 653
Zhiyuan Xiao China 18 495 1.4× 79 0.4× 242 1.4× 335 2.7× 8 0.1× 31 847
Philip A. Knobel Spain 13 517 1.4× 188 0.9× 88 0.5× 160 1.3× 8 0.1× 15 737
Cecilia Roux South Africa 13 344 1.0× 207 1.0× 152 0.9× 132 1.1× 4 0.1× 34 724
Gerald F. Casperson United States 16 664 1.9× 182 0.9× 66 0.4× 31 0.3× 28 0.4× 22 942

Countries citing papers authored by Heming Zhou

Since Specialization
Citations

This map shows the geographic impact of Heming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heming Zhou more than expected).

Fields of papers citing papers by Heming Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heming Zhou. The network helps show where Heming Zhou may publish in the future.

Co-authorship network of co-authors of Heming Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Heming Zhou. A scholar is included among the top collaborators of Heming Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heming Zhou. Heming Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhou, Heming, Huarong Chen, Weixin Liu, et al.. (2025). Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. Nature Communications. 17(1). 803–803.
2.
Zhou, Heming, Yafei Wu, Jigang Zhang, et al.. (2024). Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma. Experimental Cell Research. 436(1). 113956–113956. 4 indexed citations
3.
Yang, Huihua, Dahong Chen, Yafei Wu, et al.. (2023). A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC. SHILAP Revista de lepidopterología. 11(1). 27–27. 20 indexed citations
5.
Zhou, Heming, Jigang Zhang, Xue Zhang, & Li Qin. (2021). Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduction and Targeted Therapy. 6(1). 300 indexed citations breakdown →
7.
Wu, Yafei, Jigang Zhang, Xue Zhang, et al.. (2020). Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Frontiers in Pharmacology. 11. 198–198. 38 indexed citations
8.
Zhang, Jigang, et al.. (2020). Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling. BMC Cancer. 20(1). 32–32. 53 indexed citations
9.
Zhang, Xue, et al.. (2019). Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry. Journal of Cancer. 10(25). 6327–6340. 60 indexed citations
10.
Zhou, Heming, et al.. (2019). Overlapping and unique roles played by ROCK1 and 2 in the modulation of coding and long noncoding RNA expression. BMC Genomics. 20(1). 409–409. 3 indexed citations
11.
Wang, Yuanyuan, Hongbin Tao, Beijing Tian, et al.. (2018). Flowering dynamics, pollen, and pistil contribution to grain yield in response to high temperature during maize flowering. Environmental and Experimental Botany. 158. 80–88. 136 indexed citations
12.
Li, Chuangmin, et al.. (2009). Alleviating Crack Properties of Crack Alleviating Mixture. 1754–1759. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026